Sign In
Buy BNTX
$89.59
+1.14 (+1.29%)
At Close: Jun 04, 2026
Pfizer und BioNTech erhalten positive CHMP-Empfehlung für Auffrischungsimpfung mit Omikron BA.1-angepasstem bivalenten COVID-19-Impfstoff in der Europäischen Union
01:45pm, Thursday, 01'st Sep 2022 GlobeNewswire Inc.
NEW YORK und MAINZ, Deutschland, 1. September 2022 — Pfizer Inc. (NYSE: PFE, „Pfizer“) und BioNTech SE (Nasdaq: BNTX, „BioNTech“) gaben heute bekannt, dass der Ausschuss für Humanarzneimitt
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union
01:45pm, Thursday, 01'st Sep 2022 GlobeNewswire Inc.
NEW YORK and MAINZ, GERMANY, September 1, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a 30 µg booster dose of their Omicron BA.1- Bivalent COVID-19 Vaccine (COMIRN
FDA Authorizes Pfizer, Moderna's Omicron-Based Boosters
12:23pm, Thursday, 01'st Sep 2022
Pfizer (PFE)/BioNTech (BNTX) and Moderna (MRNA) develop the Omicron BA.4/BA.5-adapted bivalent vaccines at the FDA's recommendation.
Why Novavax Stock Got Pummeled Today
10:45pm, Wednesday, 31'st Aug 2022 The Motley Fool
The coronavirus' decline is continuing; meanwhile, rival vaccine developers are still moving ahead.
Why Moderna Stock Slumped on Wednesday
09:04pm, Wednesday, 31'st Aug 2022 The Motley Fool
Good news for the world lowers bullishness on the company's future.
Biotech Hasn't Been This Blazing Hot Since Early 2021 — Here Are The Top 5
03:26pm, Wednesday, 31'st Aug 2022
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older
02:12pm, Wednesday, 31'st Aug 2022 GlobeNewswire Inc.
NEW YORK and MAINZ, GERMANY, August 31, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authoriza
Pfizer und BioNTech erhalten FDA-Notfallzulassung für Auffrischungsimpfung mit an Omikron BA.4/BA.5 angepassten bivalenten COVID-19-Impfstoff für Personen ab 12 Jahren
02:12pm, Wednesday, 31'st Aug 2022 GlobeNewswire Inc.
NEW YORK und MAINZ, Deutschland, 31. August 2022 — Pfizer Inc. (NYSE: PFE, „Pfizer“) und BioNTech SE (Nasdaq: BNTX, „BioNTech“) gaben heute bekannt, dass die US-amerikanische Arzneimittelbeh
Should Pfizer Investors Be Worried About Moderna's Lawsuits?
09:52am, Wednesday, 31'st Aug 2022 The Motley Fool
Pfizer and BioNTech plan to aggressively defend against Moderna's claims of patent infringement.
Moderna's (MRNA) Omicron Based Jab gets Approval in Australia
05:11pm, Tuesday, 30'th Aug 2022 Zacks Investment Research
Moderna (MRNA) receives provisional approval in Australia for its Omicron-containing bivalent booster vaccine mRNA-1273.214 in adults, making it the first bivalent COVID-19 vaccine approved for use in
After Double-Digit Percentage Declines, Are Vaccine Stocks Buys?
10:00am, Tuesday, 30'th Aug 2022 The Motley Fool
They still might offer solid long-term opportunities for investors.
US Stock Futures Higher Ahead Of Economic Data, Fed Speakers
09:24am, Tuesday, 30'th Aug 2022 Benzinga
Pre-open movers
U.S. stock futures traded higher in early pre-market trade as investors digested comments from Federal Reserve Chairman Jerome Powell. Markets closed lower again on Monday, with the Na
Pfizer-BioNTech, Moderna Set To Get FDA Nod For Omicron Booster Shots As Early As Wednesday: Report
06:34am, Tuesday, 30'th Aug 2022 Benzinga
Booster shots for Omicron variants of the novel coronavirus could officially be made available in the U.S. just after Labor Day, Politico reported on Monday.
What Happened: The Food and Drug Administr
After Double-Digit Percentage Declines, Are Vaccine Stocks Buys?
06:00am, Tuesday, 30'th Aug 2022
They still might offer solid long-term opportunities for investors.
Pfizer (PFE), BioNTech Seek EU Nod for Omicron-Based Booster
04:05pm, Monday, 29'th Aug 2022 Zacks Investment Research
Pfizer (PFE) and BioNTech (BNTX) complete submission of conditional marketing authorization to the European Medicines Agency for Omicron BA.4/BA.5-adapted bivalent vaccine.
